BioXcel Therapeutics rises on narrower Q4 loss

BioXcel Therapeutics

12/03/2024 11:59

** Shares of BioXcel Therapeutics  BTAI.O  rise 6.9% to
$3.10 premarket
    ** Co posts a narrower Q4 loss of 76 cents/shr vs $1.95/shr
a year ago
    ** However, co's Q4 rev of $376,000 missed Wall Street
estimates of $711,000 - LSEG data
    ** Up to last close, stock down 86% in the last 12 months

 (Reporting by Puyaan Singh)
 ((Puyaan.Singh@thomsonreuters.com;))